StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
15
Publishing Date
2021 - 10 - 18
15
Sector
Health technology
14
Manufacturing
1
Tags
Acquisition
5
Alliances
4
Application
6
Approval
4
Automotive
3
Biotech
3
Biotech-beach
3
Biotechnology
3
Brands
3
Cancer
5
Ceo
3
Children
3
China
3
Collaboration
7
Commercialization
6
Conference
32
Contract
8
Covid
5
Covid-19
3
Designation
3
Diagnostic
3
Disease
5
Distribution
5
Drug
6
Earnings
4
Ema
10
Energy
11
Europe
3
Events
13
Expansion
5
Fda
8
Financial results
18
Food
3
Ford
4
Gene therapy
3
Grant
4
Granted
4
Growth
18
Hiv
3
Iot
4
Liver
5
Media
7
Merge
6
Mobile
5
N/a
339
Offering
9
Partnership
4
People
7
Phase 3
7
Positive
4
Presentation
7
Program
4
Research
14
Results
41
Sales
7
Semiconductor
4
Technology
7
Therapy
6
Treatment
15
Trial
14
Entities
Adamis pharmaceuticals corporation
1
Alkermes plc
1
Alnylam pharmaceuticals, inc.
1
Aslan pharmaceuticals limited
1
Astria therapeutics, inc.
1
Avidity biosciences, inc.
1
Bioxcel therapeutics, inc.
1
Eli lilly and company
2
Gilead sciences, inc.
1
Incyte corporation
1
Moleculin biotech, inc.
1
Omeros corporation
1
Oyster point pharma, inc.
1
Ultragenyx pharmaceutical inc.
1
Vertex pharmaceuticals incorporated
1
Vivos therapeutics inc
1
Symbols
ADMP
1
ALKS
1
ALNY
1
ASLN
1
ATXS
1
BTAI
1
GILD
1
INCY
1
LLY
2
MBRX
1
OMER
1
OYST
1
RARE
1
RNA
1
VRTX
1
VVOS
1
Exchanges
Nasdaq
15
Nyse
2
Crawled Date
2024 - 03 - 19
12
2024 - 03 - 04
13
2023 - 12 - 12
13
2023 - 12 - 06
14
2023 - 11 - 27
12
2023 - 10 - 18
12
2023 - 10 - 16
16
2023 - 10 - 04
14
2023 - 09 - 26
17
2023 - 09 - 20
12
2023 - 09 - 07
14
2023 - 08 - 23
12
2023 - 06 - 26
13
2023 - 04 - 25
13
2023 - 04 - 17
14
2023 - 02 - 23
12
2023 - 01 - 30
16
2023 - 01 - 25
14
2022 - 11 - 17
12
2022 - 10 - 12
13
2022 - 09 - 14
12
2022 - 08 - 22
13
2022 - 05 - 17
13
2022 - 03 - 28
14
2022 - 01 - 24
16
2021 - 12 - 13
15
2021 - 12 - 09
12
2021 - 12 - 06
14
2021 - 11 - 12
11
2021 - 11 - 01
12
2021 - 10 - 25
11
2021 - 10 - 19
11
2021 - 10 - 18
15
2021 - 10 - 14
12
2021 - 10 - 12
12
2021 - 10 - 07
13
2021 - 10 - 04
12
2021 - 09 - 30
11
2021 - 09 - 09
11
2021 - 09 - 07
12
2021 - 08 - 24
11
2021 - 07 - 13
11
2021 - 06 - 29
12
2021 - 06 - 28
11
2021 - 06 - 25
13
2021 - 06 - 23
14
2021 - 06 - 21
13
2021 - 06 - 11
11
2021 - 06 - 04
13
2021 - 06 - 03
12
2021 - 06 - 01
14
2021 - 05 - 21
15
2021 - 05 - 03
13
2021 - 04 - 30
11
2021 - 04 - 15
11
2021 - 03 - 22
14
2020 - 12 - 15
14
2020 - 12 - 03
11
2020 - 12 - 02
12
2020 - 12 - 01
18
Crawled Time
01:00
1
10:00
1
11:00
1
12:00
1
13:00
2
14:00
2
17:00
1
18:00
4
19:00
2
Source
www.aslanpharma.com
1
www.biospace.com
12
www.prnewswire.com
2
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Treatment
crawled date :
2021 - 10 - 18
save search
Alkermes Announces Commercial Availability of LYBALVI® for the Treatment of Schizophrenia and Bipolar I Disorder
Published:
2021-10-18
(Crawled : 19:00)
- biospace.com/
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
205.67%
|
O:
0.14%
H:
1.98%
C:
0.43%
ALKS
|
$23.86
0.42%
0.42%
2.4M
|
Health Technology
|
-24.69%
|
O:
0.03%
H:
0.0%
C:
-4.36%
treatment
schizophrenia
commercialization
BioXcel Therapeutics Announces Expansion of Phase 2 Trial of BXCL701 in De Novo and Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer
Published:
2021-10-18
(Crawled : 19:00)
- biospace.com/
BTAI
|
$2.77
8.63%
7.94%
620K
|
Health Technology
|
-89.85%
|
O:
0.15%
H:
6.75%
C:
3.39%
treatment
phase 2
prostate cancer
expansion
endocrine
cancer
trial
merge
Adamis Receives FDA Approval for ZIMHINew High-Dose Naloxone Product for the Treatment of Opioid Overdose
Published:
2021-10-18
(Crawled : 18:00)
- biospace.com/
ADMP
|
$0.7751
0.86%
2.6%
120K
|
Health Technology
|
-31.41%
|
O:
23.01%
H:
6.47%
C:
-11.51%
treatment
fda
opioid
fda approval
approval
Alnylam Receives Positive Reimbursement Recommendation from the Canadian Agencies for Drugs and Technology in Health (CADTH) for use of GIVLAARI for the Treatment of Acute Hepatic Porphyria (AHP) in Adults
Published:
2021-10-18
(Crawled : 18:00)
- biospace.com/
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-30.76%
|
O:
0.14%
H:
0.0%
C:
-2.37%
treatment
positive
drug
technology
hepatitis
Vertex Announces Positive Day 90 Data for the First Patient in the Phase 1/2 Clinical Trial Dosed With VX-880, a Novel Investigational Stem Cell-Derived Therapy for the Treatment of Type 1 Diabetes
Published:
2021-10-18
(Crawled : 18:00)
- biospace.com/
VRTX
|
News
|
$394.43
0.24%
0.24%
1.3M
|
Health Technology
|
116.91%
|
O:
0.4%
H:
0.11%
C:
-0.93%
diabetes
treatment
stem cell
phase 1
positive
therapy
trial
Vivos Therapeutics and Candid Announce Strategic Collaboration to Deliver A Comprehensive Sleep Apnea and Orthodontic Treatment Solution
Published:
2021-10-18
(Crawled : 18:00)
- biospace.com/
VVOS
|
$2.72
2.26%
2.21%
34K
|
Health Technology
|
-23.38%
|
O:
2.25%
H:
10.74%
C:
6.89%
treatment
collaboration
liver
Ultragenyx Initiates Cyprus2+, a Pivotal Clinical Trial Evaluating UX701 Gene Therapy for the Treatment of Wilson Disease
Published:
2021-10-18
(Crawled : 17:00)
- biospace.com/
RARE
|
News
F
|
$42.37
-2.33%
-2.38%
680K
|
Health Technology
|
-47.04%
|
O:
-1.4%
H:
0.27%
C:
-1.09%
disease
treatment
gene therapy
therapy
trial
FDA Grants Fast Track Designation to AOC 1001 for the Treatment of Myotonic Dystrophy Type 1
Published:
2021-10-18
(Crawled : 14:00)
- biospace.com/
RNA
|
$22.74
-1.3%
-1.32%
1M
|
Health Technology
|
5.62%
|
O:
-0.28%
H:
3.54%
C:
-4.94%
treatment
fda
fast track
fast track designation
granted
grant
designation
Astria Therapeutics Presents Findings on Burdens of Disease and Treatment in Hereditary Angioedema at the 2021 NORD Rare Diseases and Orphan Products Breakthrough Summit
Published:
2021-10-18
(Crawled : 14:00)
- biospace.com/
ATXS
|
$9.745
-7.54%
-8.16%
1.2M
|
Manufacturing
|
38.69%
|
O:
-0.43%
H:
1.14%
C:
-7.14%
disease
treatment
ema
rare
hereditary angioedema
Moleculin Announces Interim Data in Phase 1b/2 Clinical Trial of Annamycin for the Treatment of Soft Tissue Sarcoma Lung Metastases
Published:
2021-10-18
(Crawled : 13:00)
- biospace.com/
MBRX
|
$4.65
2.8%
2.72%
11K
|
Health Technology
|
71.59%
|
O:
3.32%
H:
0.0%
C:
-4.29%
treatment
phase 1
trial
phase 1b
soft tissue
phase 2b
U.S. Food and Drug Administration Approves Expanded Indication of Gilead’s Biktarvy® for Treatment of HIV-1 in Pediatric Populations
Published:
2021-10-18
(Crawled : 13:00)
- biospace.com/
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-2.91%
|
O:
-1.83%
H:
0.13%
C:
-2.37%
food
treatment
drug
hiv
xin
Omeros Receives Complete Response Letter from FDA for Biologics License Application for Narsoplimab in the Treatment of HSCT-TMA
Published:
2021-10-18
(Crawled : 12:00)
- biospace.com/
OMER
|
$3.045
-5.14%
-5.42%
390K
|
Health Technology
|
-60.95%
|
O:
-21.64%
H:
0.49%
C:
-7.35%
treatment
fda
application
license
response
ASLAN Pharmaceuticals Announces KOL Event Series to Discuss Atopic Dermatitis Treatment Landscape and ASLAN004
Published:
2021-10-18
(Crawled : 11:00)
- aslanpharma.com
ASLN
|
News
|
$0.54
0.0%
26K
|
Health Technology
|
-68.32%
|
O:
-1.86%
H:
4.43%
C:
0.63%
treatment
dermatitis
atopic dermatitis
Oyster Point Pharma Announces FDA Approval of TYRVAYA™ (varenicline solution) Nasal Spray for the Treatment of the Signs and Symptoms of Dry Eye Disease
Published:
2021-10-18
(Crawled : 10:00)
- prnewswire.com
OYST
|
$11.17
0.18%
-0.27%
|
Health Technology
|
-18.14%
|
O:
9.77%
H:
2.68%
C:
-7.29%
dry eye
disease
nasal spray
treatment
fda
eye
fda approval
eye disease
approval
Innovent Announces ORIENT-31, a Phase 3 Study of Sintilimab in Patients with EGFR-Mutated Nonsquamous Non-Small Cell Lung Cancer with Prior EGFR-TKI Treatment, Has Met Primary Endpoint
Published:
2021-10-18
(Crawled : 01:00)
- prnewswire.com
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
205.67%
|
O:
0.14%
H:
1.98%
C:
0.43%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
-20.19%
|
O:
-0.09%
H:
0.0%
C:
-1.45%
treatment
lung cancer
cancer
phase 3
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.